Treatment of amyotrophic lateral sclerosis using umbilical derived cells
US8491883B2 · kind B2 · utility
4Cited by
79References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 14, 2011 |
| Grant date | Jul 23, 2013 |
| Priority date | — |
| Expiry date | Jul 24, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2533/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to methods of treating amyotrophic lateral sclerosis. In particular, the invention provides for methods of treating amyotrophic lateral sclerosis by administering umbilical cord tissue-derived cells, an effective amount of a substantially homogenous population of umbilical cord tissue-derived cells or a pharmaceutical composition comprising umbilical cord tissue-derived cells to a patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.